TAIWAN BIOTECH CO., LTD.September 11, 2017

FDA 483 - TAIWAN BIOTECH CO., LTD. - September 11, 2017

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore TAIWAN BIOTECH CO., LTD.

Record Details

TAIWAN BIOTECH CO., LTD. in Taoyuan City, Taiwan, was inspected regarding its sterile drug manufacturing operations. The inspection revealed significant deficiencies in environmental monitoring for aseptic processing, failures in following the stability testing program, and inadequate record-keeping for quality evaluations and deviation tracking. These issues indicate a lack of robust quality control and data integrity practices.

Company: TAIWAN BIOTECH CO., LTD.
Inspection Date: September 11, 2017
Product Type: Drugs
Office: Office of Inspections and Investigations
Person: Ileana Barreto-Petit

Open in Dashboard

ID · 3621a836-8e2f-4d1f-952a-9c4838edcb01